Dataset
Association of rs2046210 and rs12662670 with risk of ER−*/ER+** breast cancer.
Affiliations
Organisations
- (1) University of Melbourne, grid.1008.9
- (2) National Institute for Public Health and the Environment, grid.31147.30
- (3) Institute of Cancer Research, grid.18886.3f
- (4) National Institute for Health Research, grid.451056.3
- (5) Heidelberg University, grid.7700.0
- (6) University of Copenhagen, grid.5254.6, KU
- (7) Hospital Monte Naranco, grid.414858.4
- (8) Hospital Universitario La Paz, grid.81821.32
- (9) Hannover Medical School, grid.10423.34
- (10) Institute of Biochemistry and Genetics of Ufa Scientific Centre, grid.429129.5
- (11) Karolinska Institute, grid.4714.6
- (12) Oslo University Hospital, grid.55325.34
- (13) Erasmus University Medical Center, grid.5645.2
- (14) Pomeranian Medical University, grid.107950.a
Countries
Continents
Description
Results are presented overall as well as separately for Europeans and Asians. Pooled analyses adjusted for the studies were performed. A log-additive genetic model was assumed.*Estrogen receptor negative.**Estrogen receptor positive.aOdds ratio per minor allele (A allele for rs2046210, G allele for rs12662670) derived from case-control logistic regression restricted to ER+ or ER− cases, respectively, and the whole control sample.bP-value derived from the log-additive model derived from case-control logistic regression restricted to ER+ or ER− cases, respectively, and the whole control sample.cP-value for heterogeneity between estimates of genetic main effects derived from case-only analysis.